PRHB Pure H2O Bio Technologies Inc New (CE)

Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announced today its concerns over metropolitan water systems. There have been recent public concerns in Colorado and Florida regarding failures in their metropolitan water systems. Many are due to the aging delivery systems that are breaking down at the point of entry or point of use, which results in high levels of contamination with pathogenic microorganisms. Although the most common contaminants will be organisms such as E. coli, Salmonella, or Pseudomonas, there has been a significant rise in organisms that are resistant to chlorine and related halogens such as fluorine and bromine. The general way that metropolitan water districts try to solve the problem is by flushing out the system and the introduction of high levels of free chlorine (a very toxic substance which is also corrosive to the pipes used to deliver water to the public). "This extremely important disinfection technology developed by PRHB will provide an opportunity to address the concerns around the world on clean water. Recent public concerns over unacceptable contaminants in public water are increasing," said the Executive Producer of the Global News Group. "I am looking forward to presenting the story in an upcoming Special Edition report on this very important breakthrough." In the recent past, there has been a significant increase in Cryptosporidium detected in public swimming pools throughout the country. Further, Noroviruses have entered the environment, namely on cruise ships. This means that infected individuals will continue to spread such pathogens and they will very likely enter the drinking water systems at increasing rates. Organisms such as Cryptosporidium, Giardia, and various viruses are virtually resistant to treatment with chlorine and other related halogens as well as chemicals such as pesticides and various prescription/over-the-counter pharmaceuticals. These organisms are not resistant to treatment with the SilverTTO which has been tested by Pure H2O Bio-technologies, Inc., (PRHB) in laboratory level studies and is now being verified with the state-of-the-art patent-pending treatment/delivery system that is underway. The system is also designed to remove chemical contaminants and metals that are present in source water. Certification of this system through EPA's contractor, National Sanitation Foundation (NSF) is expected to be completed within a few short months and has a high likelihood for success. This system will be available to individuals and hospitals as a system delivering "pathogen-free and chemical-free" water. Pure H2O Bio-Technologies, Inc., www.pureh20biotech.com, has been developing a water treatment system designed to kill the pathogenic microbes such as those cited above and to deliver highly purified water at the point-of-entry (POE) and point-of-use (POU), namely for residential, commercial, hospital and medical facilities. "Our potable water disinfection systems, in the near-final and certification testing stages, can provide both disinfection and purification of the contaminated water. On July 31, 2007, the Company was awarded patent #7250111, and two additional patents pending at this time that are under review with the U.S. Patent and Trademark Office, Washington, D.C.," stated Joseph P. Doxey, President of Pure H2O Bio-Technologies, Inc. About Pure H2O Bio-Technologies, Inc.: Pure H2O Bio-Technologies, Inc. (PRHB) is a publicly held company specializing in the manufacturing, design, and sale of its unique residential, commercial and hospital point-of-use potable water disinfection systems. These systems are specifically designed to work effectively against water-borne pathogens and remove heavy metals and objectionable biomasses. The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," "potential," "suggests," "may," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations regarding future research, development, and/or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the Company's ability to obtain or maintain patent and other proprietary intellectual property protection; and completion in general. Forward-looking statements speak only as to the date they were made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.